During the past decade, Saiseikai Niigata Daini Hospital conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Saiseikai Niigata Daini Hospital" #1 collaborator was "Gilead Sciences" with 3 trials as a collaborator, "Tokyo Medical and Dental University" with 2 trials as a collaborator and "Galapagos NV" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Saiseikai Niigata Daini Hospital" are "Colorectal Cancer" (2 trials), "Crohn's Disease" (2 trials) and "Ulcerative Colitis" (2 trials). Many other conditions were trialed in "Saiseikai Niigata Daini Hospital" in a lesser frequency.

Most popular intervention types in "Saiseikai Niigata Daini Hospital" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Filgotinib" (4 trials), "Placebo" (2 trials), "UFT adjuvant chemotherapy" (2 trials), "PTM filgotinib" (1 trials) and "Placebo to match filgotinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Saiseikai Niigata Daini Hospital" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Saiseikai Niigata Daini Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 4 completed trials in Saiseikai Niigata Daini Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Saiseikai Niigata Daini Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".